CymaBay Therapeutics to Report First Quarter 2020 Financial Results on Monday, May 11
May 04 2020 - 4:43PM
CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage
biopharmaceutical company focused on developing therapies for liver
and other chronic diseases with high unmet need, today announced
that it will host a conference call and live audio webcast on
Monday, May 11, 2020 at 4:30 p.m. Eastern Time to discuss financial
results for the first quarter ended March 31, 2020 and to provide a
business update.
Conference Call DetailsTo
access the live conference call, please dial 855-327-6837 from the
U.S. and Canada, or 631-891-4304 internationally, Conference ID#
10009543. To access the live and subsequently archived webcast of
the conference call, go to the Investors section of the company's
website at http://ir.cymabay.com/events.
About CymaBay
CymaBay Therapeutics, Inc. is a clinical-stage
biopharmaceutical company focused on developing therapies for liver
and other chronic diseases with high unmet medical need.
For additional information about CymaBay visit
www.cymabay.com.
Contact:Sloane & CompanyDan
Zacchei / Joe Germani, 212-486-9500Dzacchei@sloanepr.com /
JGermani@sloanepr.com
Cymabay Therapeutics (NASDAQ:CBAY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cymabay Therapeutics (NASDAQ:CBAY)
Historical Stock Chart
From Apr 2023 to Apr 2024
